N/A
N=27
Physiotherapy in the Haemophilic Arthropathy of the Elbow.
Patients With Hemophilia
Bottom Line
View on ClinicalTrials.gov: NCT02198040 ↗Enrolled (actual)
27
Serious AEs
0.0%
Results posted
Feb 2017
Primary outcome: Primary: Changes in Range of Motion of Elbow — 138.31; 136.13; 138.00; 135.56 degrees
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Manual Therapy (Other); Educational group (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- Male
- Sponsor
- Universidad Católica San Antonio de Murcia
- Primary completion
- Oct 2012
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Changes in Range of Motion of Elbow |
138.31; 136.13; 138.00; 135.56; 140.31; 138.43 | — |
| PRIMARY Changes in the Circumference of Arm |
31.125; 31.331; 32.007; 31.23; 31.72; 31.85 | — |
| PRIMARY Changes in Biceps Strength |
0.000; 0.094; 0.143; 0.03; 0.00; 0.07 | — |
| PRIMARY Changes in the Pain Perception of Elbow |
0.156; 0.719; 0.143; 0.09; 0.34; 0.07 | — |
| PRIMARY Assessment of Radiological Joint Deterioration |
9.63; 8.50; 7.57 | — |
| SECONDARY Characteristics of the Patients |
33.78; 32.33; 37.33 | — |
| SECONDARY Frequency of Elbow Hemarthrosis |
1.06; 1.06; 0.71; 0.00; 0.00; 0.62 | — |
Summary
The aim of this study is to assess the effectiveness of two treatments of Physiotherapy: one with joint traction, passive muscles stretching and Proprioceptive Neuromuscular Facilitation (PNF), and the other with education sessions and home exercises, for the improvement of the ROM, biceps strength, perimeter of arm and the perception of pain in PwH and arthropathy of the elbow.
Eligibility Criteria
Inclusion Criteria
- Patients over 18 years
- Patients diagnosed with hemophilia A or B
- Patients with hemophilic arthropathy in one or both elbows
Exclusion Criteria
- Patients with another medical diagnosis (eg, Von Willebrand's disease)
- Patients with presence of antibodies to FVIII or FIX (inhibitors)
- Patients who had a haemarthrosis of elbow during the study
Data sourced from ClinicalTrials.gov (NCT02198040). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.